Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

BriaCell Therapeutics Corp. BCTX

Full chart Compare
Set alert

Price alert · BCTX

All alert types
3.21 USD +0.20 (+6.64%)

Nov 4, 2026, 1:51 PM EST

3.02 Day range 3.26
2.60 52-week range 13.09
YTD
-54.85%
1 year
-68.15%

Financial health

Altman Z-Score

-10.64 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 3
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 4

Valuation

P/E -0.5×
FY 2017: -5.7×FY 2018: -3.3×FY 2019: -1.9×FY 2020: -257×FY 2021: -56.4×FY 2022: -3.7×FY 2023: -5.2×FY 2024: -2.6×FY 2025: -0.1×FY 2026: -0.5×
FY 2017 5y median -2.6× FY 2026
P/S 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
P/B 1.1×
FY 2017: 231×FY 2018: 178×FY 2019: -160×FY 2020: -19.1×FY 2021: 6.6×FY 2022: 75.0×FY 2023: -207×FY 2024: -37.4×FY 2025: 0.6×FY 2026: 1.1×
FY 2017 5y median 0.6× FY 2026
P/FCF -0.6×
FY 2017: -90.5×FY 2018: -34.0×FY 2019: -21.5×FY 2020: -44.3×FY 2021: -23.2×FY 2022: -62.6×FY 2023: -32.8×FY 2024: -3.7×FY 2025: -0.4×FY 2026: -0.6×
FY 2017 5y median -3.7× FY 2026
EV/EBITDA -0.2×
FY 2017: -53.4×FY 2018: -31.4×FY 2019: -19.1×FY 2020: -14.3×FY 2021: -9.2×FY 2022: -27.3×FY 2023: -32.7×FY 2024: -25.3×FY 2025: 0.0×FY 2026: -0.2×
FY 2017 5y median -25.3× FY 2026
EV/Sales 0.0×
FY 2017: 0.0×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
FCF Yield -167.0%
FY 2017: -1.1%FY 2018: -2.9%FY 2019: -4.6%FY 2020: -2.3%FY 2021: -4.3%FY 2022: -1.6%FY 2023: -3.1%FY 2024: -27.1%FY 2025: -278.0%FY 2026: -167.0%
FY 2017 5y median -27.1% FY 2026

Profitability

Gross Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Operating Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Net Margin 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
ROE -212.8%
FY 2017: -428.9%FY 2018: -572.2%FY 2019: 844.8%FY 2020: 137.4%FY 2021: -49.9%FY 2022: -259.8%FY 2023: 537.5%FY 2024: 144.9%FY 2025: -148.4%FY 2026: -212.8%
FY 2017 5y median -148.4% FY 2026
ROIC -228.3%
FY 2017: -428.5%FY 2018: -240.7%FY 2019: 1707.7%FY 2020: 165.3%FY 2021: -12.1%FY 2022: -36.7%FY 2023: -91.8%FY 2024: 1511.6%FY 2025: -155.3%FY 2026: -228.3%
FY 2017 5y median -91.8% FY 2026
ROA -148.0%
FY 2017: -196.6%FY 2018: -236.7%FY 2019: -1308.4%FY 2020: -946.3%FY 2021: -23.8%FY 2022: -63.0%FY 2023: -74.7%FY 2024: -58.8%FY 2025: -122.6%FY 2026: -148.0%
FY 2017 5y median -74.7% FY 2026

Growth (YoY)

Revenue 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 FY 2026
Operating Income 5.6%
FY 2017: -46.5%FY 2018: -54.6%FY 2019: -25.8%FY 2020: 15.6%FY 2021: -65.2%FY 2022: -125.0%FY 2023: -58.5%FY 2024: -7.3%FY 2025: -13.2%FY 2026: 5.6%
FY 2017 FY 2026
EPS (diluted) 88.9%
FY 2017: 0.9%FY 2018: -33.3%FY 2019: 16.3%FY 2020: 99.6%FY 2021: -139.4%FY 2022: -1822.2%FY 2023: 24.9%FY 2024: 77.9%FY 2025: -45.5%FY 2026: 88.9%
FY 2017 FY 2026
Free Cash Flow 26.3%
FY 2017: -21.1%FY 2018: -159.2%FY 2019: -3.3%FY 2020: 69.6%FY 2021: -536.0%FY 2022: -60.5%FY 2023: -100.9%FY 2024: -5.3%FY 2025: -16.3%FY 2026: 26.3%
FY 2017 FY 2026

Financial Health

Current Ratio 2.8×
FY 2017: 1.8×FY 2018: 1.4×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 104×FY 2022: 45.0×FY 2023: 15.0×FY 2024: 0.5×FY 2025: 5.0×FY 2026: 2.8×
FY 2017 5y median 5.0× FY 2026
Quick Ratio 2.8×
FY 2017: 1.8×FY 2018: 1.4×FY 2019: 0.1×FY 2020: 0.1×FY 2021: 104×FY 2022: 45.0×FY 2023: 15.0×FY 2024: 0.5×FY 2025: 5.0×FY 2026: 2.8×
FY 2017 5y median 5.0× FY 2026
Debt / Equity 0.0×
FY 2017: 0.0×FY 2018: 1.2×FY 2019: -0.5×FY 2020: -0.1×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026
Net Debt / EBITDA 0.3×
FY 2017: 0.3×FY 2018: -0.1×FY 2019: -0.0×FY 2020: -0.0×FY 2021: 4.2×FY 2022: 1.5×FY 2023: 0.9×FY 2024: 0.2×FY 2025: 0.4×FY 2026: 0.3×
FY 2017 5y median 0.4× FY 2026
Interest Coverage 0.0×
FY 2017: 0.0×FY 2018: -244×FY 2019: -199×FY 2020: -146×FY 2021: -87.0×FY 2022: -15762×FY 2023: 0.0×FY 2024: 0.0×FY 2025: -736×FY 2026: 0.0×
FY 2017 5y median 0.0× FY 2026

Dividends

Dividend Yield 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026
Payout Ratio 0.0%
FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%FY 2026: 0.0%
FY 2017 5y median 0.0% FY 2026

Annual · latest fiscal year ends 2026-07-31